Last updated on May 2018

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis


Brief description of study

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis (JIA) with particular in interest in the occurrence of serious infections, autoimmune disorders, and malignancies.

Clinical Study Identifier: NCT01357668

Find a site near you

Start Over

Emmed Research

Pretoria, South Africa
4.77miles
  Connect »

Clinical Research Unit

Pretoria, South Africa
5.84miles
  Connect »